Concepedia
Statistics
Publications
3
Citations
41
H-Index
Active since
2012
Affiliations
Oncology Hematology Care(Current)
Tennessee Oncology
Florida Hospital Cancer Institute
Sarah Cannon
Evan Lang is an author at Oncology Hematology Care specializing in immunotherapy, endocrine oncology, and oncology pharmacotherapy.
Publications per year
2012–2022
A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers
Johanna C. Bendell, Ahmed Zakari, Evan Lang et al. · Cancer Investigation · 2016 · 17 citations
Medicine, Oncology, Pharmacology +15
Bevacizumab, pertuzumab, and sandostatin for patients (pts) with advanced neuroendocrine cancers (NET).
Irfan Firdaus, Kent C. Shih, Ahmed Zakari et al. · Journal of Clinical Oncology · 2012 · 12 citations
Medicine, Pharmacology, Pharmacotherapy +15
Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report
Evan Lang, Brenda Sande, Samantha Brodkin et al. · Therapeutic Advances in Hematology · 2022 · 12 citations · Full text
Life Sciences, Immunology, Internal Medicine +12
1–3 of 3